Houston – October marks Breast Cancer Awareness Month when conversations surround detection and screenings. There is one form of breast cancer that doesn’t come up in conversations—Inflammatory Breast ...

Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class protein degraders for cancer and inflammatory diseases, today announced that the first patient ...

Despite recent progress in understanding the disease, inflammatory breast cancer (IBC) remains a challenge to diagnose and treat, and the prognosis remains worse than for breast cancer in general. IBC ...

New IBC diagnosis codes, effective October 1, 2025, will improve documentation, expedite treatment, and support research efforts. IBC is aggressive and often misdiagnosed due to atypical symptoms, ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a targetable driver of brain metastases in patients with aggressive inflammatory breast cancer. The study uncovers a ...

Pfizer expands oncology and immunology pipeline strength New therapies show progress in clinical development Focus shifts ...

Markers of cellular aging -- such as DNA damage response, cellular senescence, and inflammatory pathways -- significantly increased in all breast cancer survivors, regardless of the type of treatment ...

DALLAS — Jennifer Cordts, diagnosed with a rare, incurable disease called Inflammatory Breast Cancer, who lived far longer than doctors predicted and educated countless women about it, succumbed to ...

With one in every eight women diagnosed with breast cancer at some point in their lives, experts agree that early detection and treatment is key. "One of the biggest goals when it comes to breast ...